1 Sottoriva A,Kang H,Ma Z,et al.A Big Bang model of human colorectal tumor growth[J].Nat Genet,2015,47(3):209-216.
2 Navin N,Kendall J,Troge J,et al.Tumour evolution inferred by single-cell sequencing[J].Nature,2011,472(7341):90-94.
3 Greaves M,Maley CC.Clonal evolution in cancer[J].Nature,2012,481(7381):306-313.
4 Landau DA,Clement K,Ziller MJ,et al.Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia[J].Cancer Cell,2014,26(6):813-825.
5 Malanchi I,Santamaria-Martínez A,Susanto E,et al.Interactions between cancer stem cells and their niche govern metastatic colonization[J].Nature,2011,481(7379):85-89.
6 Orellana R,Kato S,Erices R,et al.Platelets enhance tissue factor protein and metastasis initiating cell markers,and act as chemoattractants increasing the migration of ovarian cancer cells[J].BMC Cancer,2015,15(1):290.
7 Eisenhoffer GT,Loftus PD,Yoshigi M,et al.Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia[J].Nature,2012,484(7395):546-549.
8 Giancotti FG.Mechanisms governing metastatic dormancy and reactivation[J].Cell,2013,155(4):750-764.
9 Marusyk A,Tabassum DP,Altrock PM,et al.Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity[J].Nature,2014,514(7520):54-58.
10 Shien K,Toyooka S,Yamamoto H,et al.Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells[J].Cancer Res,2013,73(10):3051-3061.
11 Kerkar SP,Restifo NP.Cellular constituents of immune escape within the tumor microenvironment[J].Cancer Res,2012,72(13):3125-3130.
12 Buczacki SJ,Zecchini HI,Nicholson AM,et al.Intestinal label-retaining cells are secretory precursors expressing Lgr5[J].Nature,2013,495(7439):65-69.
13 de la Puente P,Muz B,Azab F,et al.Cell trafficking of endothelial progenitor cells in tumor progression[J].Clin Cancer Res,2013,19(13):3360-3368.
14 Oshimori N,Oristian D,Fuchs E.TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma[J].Cell,2015,160(5):963-76.
15 Ajani JA,Song S,Hochster HS,et al.Cancer stem cells:The promise and the potential[J].Semin Oncol,2015,42 Suppl 1:S3-S17.
16 Katajisto P,Dhla J,Chaffer CL,et al.Stem cells.Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness[J].Science,2015,348(6232):340-343.
17 Pribluda A,de la Cruz CC,Jackson EL.Intratumoral Heterogeneity:From Diversity Comes Resistance[J].Clin Cancer Res,2015,21(13):2916-2923.
18 Turtoi A,Blomme A,Castronovo V.Intratumoral heterogeneity and consequences for targeted therapies[J].Bull Cancer,2015,102(1):17-23.
19 Wang Y,Waters J,Leung ML,et al.Clonal evolution in breast cancer revealed by single nucleus genome sequencing[J].Nature,2014,512(7513):155-160.
20 张百红,岳红云.肿瘤细胞之间的交流[J].现代肿瘤医学,2014,22(11):2744-2746.
21 张百红,岳红云.肿瘤细胞群[J].现代肿瘤医学,2014,22(6):1462-1464.
22 Kurtova AV,Xiao J,Mo Q,et al.Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance[J].Nature,2015,517(7533):209-213.
23 Quail DF,Joyce JA.Microenvironmental regulation of tumor progression and metastasis[J].Nat Med,2013,19(11):1423-1437.
24 张百红,岳红云.肿瘤细胞和亚细胞器治疗靶标的研究[J].实用肿瘤学杂志,2014,28(6):549-552.
25 Nurse P,Hayles J.The cell in an era of systems biology[J].Cell,2011,144(6):850-854.
26 张百红,岳红云.肿瘤的系统生物学观点[J].中国肿瘤临床,2012,39(16):1233-1235. |
